J 2018

Diagnosis of retrocochlear lesions with emphasis on expansion of the cerebellopontine angle

GÁL, Břetislav, Jan ROTTENBERG, Marta PAZOURKOVA, Jiří VANÍČEK, Ermis VOGAZIANOS et. al.

Basic information

Original name

Diagnosis of retrocochlear lesions with emphasis on expansion of the cerebellopontine angle

Authors

GÁL, Břetislav (203 Czech Republic, belonging to the institution), Jan ROTTENBERG (203 Czech Republic, guarantor, belonging to the institution), Marta PAZOURKOVA (203 Czech Republic), Jiří VANÍČEK (203 Czech Republic, belonging to the institution) and Ermis VOGAZIANOS (196 Cyprus)

Edition

Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2018, 1213-8118

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30206 Otorhinolaryngology

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 1.141

RIV identification code

RIV/00216224:14110/18:00103841

Organization unit

Faculty of Medicine

UT WoS

000445913000003

Keywords (in Czech)

CPA tumours, diagnosis

Keywords in English

CPA tumours; diagnosis

Tags

International impact, Reviewed
Změněno: 2/5/2019 13:56, Soňa Böhmová

Abstract

V originále

The correct diagnosis of CPA tumours is a relatively common issue in both neurological and ENT practice, the omission of which can have serious consequences for the patient. Properly set clinical guidelines and diagnostic protocols are key aspects of good clinical practice. In the case of CPA tumours, two options are available: the first is diagnosis with the help of an ABR as the primary tool for determining the group of patients with a possible tumour; the second is an MRI scan of the posterior cranial fossa. With an appropriately set diagnostic protocol in place, and despite the 40% chance of failure of the ABR to detect tumours less than or equal to 1 cm, similar treatment results can be achieved with much higher cost efficacy in case of primary ABR testing.